Evolent Health, Inc. (EVH)

Market Cap	520.07M -54.0%
Revenue (ttm)	2.10B -4.5%
Net Income	-511.06M
EPS	-4.54
Shares Out	113.06M
PE Ratio	n/a
Forward PE	13.15
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,213,089
Open	4.540
Previous Close	4.590
Day's Range	4.430 - 4.740
52-Week Range	2.095 - 10.080
Beta	0.78
Analysts	Buy
Price Target	5.77 (+25.44%)
Earnings Date	Aug 6, 2026

About EVH

Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated value-based care platform for health plan administration and management. It also provides administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, an...

• Industry: Health Information Services
• Sector: Healthcare
• IPO Date: Jun 5, 2015
• Employees: 4,200
• Stock Exchange: NYSE
• Ticker Symbol: EVH
• Website: https://www.evolent.com

Financial Performance

In 2025, Evolent Health's revenue was $1.88 billion, a decrease of -26.56% compared to the previous year's $2.55 billion. Losses were -$579.40 million, 520.0% more than in 2024.

Analyst Summary

According to 15 analysts, the average rating for EVH stock is "Buy." The 12-month stock price target is $5.77, which is an increase of 25.44% from the latest price.

Price Target

$5.77

(25.44% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence, CBOE, and more

Fundamental and historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP.

Last checked:

Aug 29, 2026

Data Sources Report a data error